Corsini Emanuela, Mitjans Montserrat, Galbiati Valentina, Lucchi Laura, Galli Corrado L, Marinovich Marina
Department of Pharmacological Sciences, Faculty of Pharmacy, Laboratory of Toxicology, University of Milan, Milan, Italy.
Toxicol In Vitro. 2009 Aug;23(5):789-96. doi: 10.1016/j.tiv.2009.04.005. Epub 2009 May 4.
Assessment of allergenic potential of chemicals is performed using animal models, such as the murine local lymph node assay, which does not distinguish between respiratory and contact allergens. Progress in understanding the mechanisms of skin sensitization, provides us with the opportunity to develop in vitro tests as an alternative to in vivo sensitization testing. The aim of the present study was to evaluate the possibility to use intracellular interleukin-18 (IL-18) production to assess in vitro the contact sensitization potential of low molecular weight chemicals. The human keratinocyte cell line NCTC2455 was used. Cells were exposed to contact allergens (cinnamaldehyde, dinitrochlorobenzene, glyoxal, isoeugenol, p-phenylediamine, resorcinol, tetramethylthiuram disulfide, 2-mercaptobenzothiazole, 4-nitrobenzylbromide), to proaptens (cinnamyl alcohol, eugenol), to respiratory allergens (diphenylmethane diisocyanate, trimellitic anhydride, ammonium hexachloroplatinate) and to irritants (sodium lauryl sulphate, salicylic acid, phenol). Cell associated IL-18 were evaluated 24 later. At not cytotoxic concentrations (cell viability higher of 75%, as assessed by MTT reduction assay), all contact sensitizers, including proaptens, induced a dose-related increase in IL-18, whereas both irritants and respiratory failed. Similar results were also obtained using primary human keratinocytes. Results were reproducible, and the method could be transferred to another laboratory, suggesting the potential use of the test in immunotoxicity testing strategies. Overall, results obtained indicated that cell-associated IL-18 may provide an in vitro tool for identification and discrimination of contact versus respiratory allergens and/or irritants.
化学物质致敏潜力的评估是使用动物模型进行的,例如小鼠局部淋巴结试验,该试验无法区分呼吸道变应原和接触性变应原。在理解皮肤致敏机制方面取得的进展,为我们提供了开发体外试验以替代体内致敏试验的机会。本研究的目的是评估利用细胞内白细胞介素-18(IL-18)的产生来体外评估低分子量化学物质接触致敏潜力的可能性。使用了人角质形成细胞系NCTC2455。将细胞暴露于接触性变应原(肉桂醛、二硝基氯苯、乙二醛、异丁香酚、对苯二胺、间苯二酚、四甲基秋兰姆二硫化物、2-巯基苯并噻唑、4-硝基苄基溴)、前变应原(肉桂醇、丁香酚)、呼吸道变应原(二苯基甲烷二异氰酸酯、偏苯三酸酐、六氯铂酸铵)和刺激物(十二烷基硫酸钠、水杨酸、苯酚)。24小时后评估细胞相关的IL-18。在无细胞毒性浓度下(通过MTT还原试验评估细胞活力高于75%),所有接触性致敏剂,包括前变应原,均诱导IL-18呈剂量相关增加,而刺激物和呼吸道变应原则无此作用。使用原代人角质形成细胞也获得了类似结果。结果具有可重复性,且该方法可转移至另一个实验室,表明该试验在免疫毒性检测策略中具有潜在用途。总体而言,所获得的结果表明细胞相关的IL-18可能为识别和区分接触性变应原与呼吸道变应原和/或刺激物提供一种体外工具。